Intercure Ltd (INCR) Stock Price, Quote & News

Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis t...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 972 7 746 05012

Fax: 972 9 768 0244

Website: www.intercure.co

Address:

85 Medinat ha-Yehudim Street, Herzliya, Israel

focafoca99 Mar. 3 at 10:36 PM

$INCR got a Nasdaq minimum bid notice

0 · Reply

BillionerOfKing Feb. 27 at 12:13 AM

$INCR Current Stock Price: $0.80 Contracts to trade: $2.5 INCR Apr 17 2026 Call Entry: $0.05 Exit: $0.08 ROI: 79% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser Feb. 26 at 4:25 AM

$INCR RSI: 39.87, MACD: -0.0412 Vol: 0.03, MA20: 0.89, MA50: 1.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ProfessorDman1 Feb. 19 at 3:43 PM

$INCR should be over $1 .. great PR this morning … added some sub .90 cents

0 · Reply

ProfessorDman1 Feb. 19 at 3:13 PM

$INCR should break $1 level ✍️🆙

0 · Reply

ProfessorDman1 Feb. 19 at 3:08 PM

$KNRX from .80s to $3 225% $INCR next one to get volume .. sub $1 buying

0 · Reply

ProfessorDman1 Feb. 19 at 2:49 PM

$INCR same chart 📊.. good PR out $KNRX 150% run ? ✍️✍️🆙

0 · Reply

DARKP00L Feb. 19 at 12:19 PM

$INCR 07:07 on Feb. 19 2026 InterCure Posts Preliminary NIS 265M Revenue For 2025, An 11% YoY Rise, With 2H Revenue Nearly 20% Higher Than Prior Year #tradeideas

0 · Reply

ProfessorDman1 Feb. 19 at 12:10 PM

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million $INCR umm 🧐 watch over 1.10 could get a run 🏃‍♂️

0 · Reply

VixTyler Feb. 17 at 9:03 AM

$INCR Obscure micro-cap; likely illiquid

0 · Reply

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million

Nov 3, 2025, 8:30 AM EST - 4 months ago

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

Oct 8, 2025, 9:40 AM EDT - 5 months ago

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

Sep 19, 2025, 8:48 AM EDT - 6 months ago

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

May 1, 2025, 4:00 PM EDT - 11 months ago

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

Feb 12, 2025, 6:35 PM EST - 1 year ago

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

Dec 20, 2024, 8:32 AM EST - 1 year ago

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Sep 14, 2024, 2:32 PM EDT - 1 year ago

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

Aug 29, 2024, 6:03 PM EDT - 1 year ago

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Aug 28, 2024, 8:54 AM EDT - 1 year ago

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

May 22, 2024, 6:45 AM EDT - 1 year ago

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

May 1, 2024, 8:27 AM EDT - 2 years ago

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

Apr 1, 2024, 9:09 AM EDT - 2 years ago

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Mar 22, 2024, 11:58 AM EDT - 2 years ago

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Feb 23, 2024, 12:12 PM EST - 2 years ago

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Feb 13, 2024, 4:46 PM EST - 2 years ago

InterCure Provides an Update Regarding Nir Oz Facility

Jan 31, 2024, 9:27 AM EST - 2 years ago

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

Oct 31, 2023, 4:39 PM EDT - 2 years ago

InterCure Wins Cannolam Arbitration Proceeding

Oct 17, 2023, 5:04 PM EDT - 2 years ago

InterCure Provides an Update Regarding the Security Situation in Israel

Aug 31, 2023, 7:45 PM EDT - 2 years ago

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Jul 10, 2023, 5:00 PM EDT - 2 years ago

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

Jun 9, 2023, 5:18 PM EDT - 3 years ago

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

May 15, 2023, 5:59 PM EDT - 3 years ago

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

May 15, 2023, 5:45 PM EDT - 3 years ago

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

Apr 25, 2023, 7:19 PM EDT - 3 years ago

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

Apr 20, 2023, 8:30 AM EDT - 3 years ago

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

Apr 3, 2023, 3:27 PM EDT - 3 years ago

InterCure Reschedules 2022 Full Year Results Conference Call

Mar 31, 2023, 8:00 PM EDT - 3 years ago

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

Feb 14, 2023, 8:30 AM EST - 3 years ago

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

Feb 1, 2023, 8:30 AM EST - 3 years ago

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

Dec 19, 2022, 8:30 AM EST - 3 years ago

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

Dec 8, 2022, 9:30 AM EST - 3 years ago

InterCure to Participate in Cowen 5th Annual Cannabis Conference

Nov 23, 2022, 4:30 PM EST - 3 years ago

Update regarding Better Transaction

Nov 17, 2022, 8:17 AM EST - 3 years ago

Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Nov 17, 2022, 8:00 AM EST - 3 years ago

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

OGI

Nov 15, 2022, 11:18 AM EST - 3 years ago

CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 15, 2022, 9:03 AM EST - 3 years ago

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 11, 2022, 8:32 AM EST - 3 years ago

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Sep 16, 2022, 4:30 PM EDT - 3 years ago

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

focafoca99 Mar. 3 at 10:36 PM

$INCR got a Nasdaq minimum bid notice

0 · Reply

BillionerOfKing Feb. 27 at 12:13 AM

0 · Reply

OfficialStocktwitsUser Feb. 26 at 4:25 AM

0 · Reply

ProfessorDman1 Feb. 19 at 3:43 PM

$INCR should be over $1 .. great PR this morning … added some sub .90 cents

0 · Reply

ProfessorDman1 Feb. 19 at 3:13 PM

$INCR should break $1 level ✍️🆙

0 · Reply

ProfessorDman1 Feb. 19 at 3:08 PM

$KNRX from .80s to $3 225% $INCR next one to get volume .. sub $1 buying

0 · Reply

ProfessorDman1 Feb. 19 at 2:49 PM

$INCR same chart 📊.. good PR out $KNRX 150% run ? ✍️✍️🆙

0 · Reply

DARKP00L Feb. 19 at 12:19 PM

$INCR 07:07 on Feb. 19 2026 InterCure Posts Preliminary NIS 265M Revenue For 2025, An 11% YoY Rise, With 2H Revenue Nearly 20% Higher Than Prior Year #tradeideas

0 · Reply

ProfessorDman1 Feb. 19 at 12:10 PM

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million $INCR umm 🧐 watch over 1.10 could get a run 🏃‍♂️

0 · Reply

VixTyler Feb. 17 at 9:03 AM

$INCR Obscure micro-cap; likely illiquid

0 · Reply

EntryStep Feb. 9 at 1:58 PM

$INCR Cannabis cultivator; operates in an oversupplied, unprofitable industry.

1 · Reply

OfficialStocktwitsUser Feb. 3 at 10:45 AM

$INCR RSI: 38.54, MACD: -0.0603 Vol: 0.03, MA20: 0.95, MA50: 1.14 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Renato17 Feb. 2 at 11:26 PM

$MSOS LIVE ON Z&A: Israel Market Outlook, Import & Export Potential @INTER_CURE $INCR $INCR.U @cronosgroup @mgorenst $CRON Pablo Zuanic @420Odysseus #Cannabis #cannabisindustry

0 · Reply

JesusWhale Jan. 8 at 1:12 PM

$INCR down 35% on no fundamental changes or news. Company needs to release some sort of update or release 2H of 2025 earnings

0 · Reply

D1gitalN0mad Jan. 2 at 4:56 PM

$INCR what in the world is going on here? $1 seems way too cheap

0 · Reply

SuperGreenToday Dec. 26 at 4:23 PM

$INCR Share Price: $1.13 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.09 – $0.11 Target Zone: $0.16 – $0.20 Potential Upside: 68% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

JesusWhale Dec. 24 at 3:34 PM

$INCR some MM is intentionally pushing this down and holding it back. Inflows have been nothing but positive, with numerous big guys over the last 5 trading sessions. I am loading the boat these prices!

0 · Reply

diamondtouch Dec. 16 at 5:12 PM

$INCR surprising this company continues to struggle despite its connection to Israel. At this time it appears management is incompetent, but time will tell. I invested in 2022 when revenue and net income was rising. Revenue was up the last two quarters but far from the $388M in 2022..

2 · Reply

WallStWireAds Dec. 12 at 8:21 PM

$INCR $TLRY $CGC $SNDL https://www.benzinga.com/content/49366233/intercure-may-be-uniquely-positioned-as-trumps-cannabis-rescheduling-returns-to-headlines-nasdaq-inc

0 · Reply

WallStWireAds Dec. 12 at 10:55 AM

$INCR https://thefinanceherald.com/trumps-rescheduling-is-back-in-play-and-this-microcap-may-be-uniquely-positioned-for-a-breakout/

0 · Reply

WallStWireAds Nov. 10 at 12:36 AM

$INCR https://thefinanceherald.com/trumps-cannabis-rescheduling-push-could-redefine-the-industry-and-intercure-is-already-expanding-its-scientific-edge/

0 · Reply

Hila11 Oct. 9 at 1:28 PM

$CGEN $INCR 🔥🚀🔥🚀 https://www.biospace.com/press-releases/intercure-reports-first-half-2025-results-with-nis-130-million-in-revenue-and-positive-operating-cash-flow

0 · Reply

Market Cap	36.00M
Revenue (ttm)	66.28M
Net Income (ttm)	-18.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-27.64%
Debt to Equity Ratio	0.22

Volume	14,800
Avg Vol	85,800
Day's Range	N/A - N/A
Shares Out	45.57M
Stochastic %K	0%
Beta	1.22
Analysts	Strong Buy
Price Target	$7.00